Drive Antimicrobial Stewardship by Eliminating False-Positive Blood Cultures

University of Nebraska's Clinical Trial on Eliminating Blood Culture Contamination

  • Event Date:
  • Event Time: 1 p.m. Central

A 3 percent false-positive blood culture rate is currently considered "acceptable." Given a national average of 8 percent positive blood cultures, 35 - 50 percent of these positive cultures are actually false-positive, including those for sepsis. Improving sepsis diagnosis can help hospitals reduce the number of patients exposed to the risks of unnecessary antibiotics and hospitalization. It can also dramatically impact the Triple Aim by improving patient safety, antimicrobial stewardship and quality outcome metrics while reducing hospital costs.

Join us to hear from Mark Rupp, MD, UNMC's Chief of Infectious Diseases, as he shares the impact a blood specimen diversion device had on blood culture testing accuracy. UNMC virtually eliminated blood culture contamination and false-positive blood culture results, demonstrating a 93 percent improvement in testing accuracy. This advancement provided improved sepsis diagnosis and avoidance of antibiotics in patients who clinically did not need them.

Barb DeBaun, RN, MSN, CIC, will facilitate the discussion including the clinical and economic impact of false-positive blood culture results.

What You Will Learn:

  • The extent of the public health challenge associated with the current standards in blood culture testing
  • The improvements achievable in patient safety, antimicrobial stewardship, quality outcome metrics and hospital costs
  • A clinical trial case study demonstrating the impact of new technology, and the achievable new standard in blood culture accuracy

Sponsored by:sponsor logo


« View All Events

Thought Leaders

Mark Rupp, MD
Professor and Chief of Infectious Diseases, Medical Director of the Department of Infection Control
Nebraska Medical Center
Mark Rupp, MD image
+Bio

Dr. Rupp is a Professor and chief of infectious Diseases and Medical Director of the Department of Infection Control at the University of Nebraska Medical Center.

Dr. Rupp received his medical degree from Baylor College of Medicine, Houston, Texas and holds a B.S. degree in Chemical Engineering from the University of Texas, Austin, Texas. He underwent internship and residency training in Internal Medicine at Virginia Commonwealth University and completed a Fellowship in Infectious Diseases at VCU.

He is a past president of SHEA and is a past-president of ASM Division L (Infection Control/Hospital Epidemiology). Dr Rupp has served as a consultant for the Food and Drug Administration as well as the Centers for Disease Control and Prevention, NIH, and VA.

Barbara DeBaun, RN, MSN, CIC
Improvement Advisor
Cynosure Health
Barbara DeBaun, RN, MSN, CIC image
+Bio

Barbara DeBaun is an Improvement Advisor for Cynosure Health. She provides individual and team coaching and facilitation to promote patient safety and quality improvement.

Barbara recently supported activities associated with the American Hospital Association (AHA) Health Research and Educational Trust (HRET) CMS Partnership for Patients Hospital Engagement Network contract and is currently supporting the AHA HIIN project. In addition, she has conducted Performance Improvement training, infection prevention program support, and medication administration ‘measureventioning’ in a variety of settings in the San Francisco Bay Area. Barbara is adjunct faculty for the MSN Nursing Program at Dominican University and is certified as a TeamSTEPPS Master Trainer. Prior to joining Cynosure Health, Barbara was an improvement advisor for BEACON, the Bay Area Patient Safety Collaborative and the Director of Patient Safety and Infection Prevention at California Pacific Medical Center in San Francisco.

Barbara is a certified Infection Prevention Practitioner (CIC) and earned a Bachelor of Science Nursing (BSN) degree from Pace University in New York and a Master of Science (MSN) degree in nursing from San Francisco State University. Barbara is an active member of APIC, the Association for Professionals in Infection Control and Epidemiology and recently served two years as an elected member of APIC Board of Directors. Prior to her board service, she served as APIC’s liaison to the Centers for Disease Control’s Hospital Infection Control Practices Advisory Committee (HICPAC).